Table 11.
Composite materials NPs | REF | Functional group | Diameter (nm) | ζ - potential (mV) | Tested Uropathogens | Activity |
---|---|---|---|---|---|---|
ZnO@ZIF8 nanocomposite | (Redfern et al., 2018) | Imidazole | 566 | – | E. coli, K. pneumoniae, P. mirabilis and S. aureus | Antibacterial |
Antibiofilm | ||||||
Silver polytetrafluorethylene nanocomposite | (Zhang et al., 2019) | – | 50 - 200 AgNps/150 PTFE Nps | – | E. coli and S. aureus | Antibacterial |
Antiadhesive | ||||||
Hydrogel containing copper nanoparticles composite | (Al-Enizi et al., 2018) | Hydroxyl and carboxyl | 7 | – | E. coli, K. pneumoniae, P. aeruginosa, P. vulgaris, S. aereus and P. mirabilis | Antibacterial |
Tetraether lipids coated silver nanoparticles embedded in a PLGA film loaded with norfloxacin | (Dayyoub et al., 2017) | – | 9.2 ± 2.5 | – | S. aereus, S. epidermidis, E. coli, E faecalis and P. aeruginosa | Antibacterial |
Silver bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide) | (Lim et al., 2015) | – | 25 -35 | -47 | UPEC, S. aureus. | Antibacterial |
Raman encoded silver coated gold nanorods | (Mahadevegowda et al., 2018) | – | 25 | -25 | UPEC | Antibacterial |